Evaluation reports
EN
VARIAPSY - Optimisation thérapeutique en neuropsychopharmacologie
Type: Research unit evaluation report
Evaluation campaign: 2017-2018 (group D)
- Published on: 11/06/2018
Institution(s) concerned:
Université Paris Descartes
, Institut national de la santé et de la recherche médicale - INSERM
, Université Paris Diderot - Paris 7
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE4 Neuroscience ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics ; LS5 Neurosciences and neural disorders: neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neuroimaging, systems neuroscience, neurological disorders, psychiatry
Name of unit teams: Equipe 1 Biomarqueurs de la Réponse Thérapeutique et de la Rechute dans les Troubles Neuropsychiatriques ; Equipe 2 - Mécanismes de Toxicité et Optimisation Thérapeutique des Psychotropes ; Equipe 3 - Barrière Hémato-Encéphalique: Physiopathologie et Thérapie
Keywords: Neuropsychopharmacologie/ neuropsychopharmacology -Toxicologie/Toxicology -Neuropharmacocinétique & Neuropharmacologie/Neuropharmacokinetics & Neuropharmacology -Biologie cellulaire/cell biology -Troubles de AR4712/mood disorders -Troubles liés à l'abu ; SVE4_1 ; SVE6